Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « important »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
importance < important < importantly  Facettes :

List of bibliographic references indexed by important

Number of relevant bibliographic references: 91.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000170 (2021) Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal]SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases.
000231 (2021) Venkata R. Emani [États-Unis] ; Sanjeev Goswami [États-Unis] ; Dheeraj Nandanoor [États-Unis] ; Shaila R. Emani [États-Unis] ; Nidhi K. Reddy [États-Unis] ; Raghunath Reddy [États-Unis]Randomised controlled trials for COVID-19: evaluation of optimal randomisation methodologies-need for data validation of the completed trials and to improve ongoing and future randomised trial designs.
000264 (2021) Yanqiang Han ; Zhilong Wang ; Jiahao Ren ; Zhiyun Wei ; Jinjin Li [République populaire de Chine]Potential inhibitors for the novel coronavirus (SARS-CoV-2).
000270 (2021) Enrico Scala [Italie] ; Luca Fania [Italie] ; Filippo Bernardini [Italie] ; Rodolfo Calarco [Italie] ; Sabrina Chiloiro [Italie] ; Cristiana Di Campli [Italie] ; Sabrina Erculei [Italie] ; Mauro Giani [Italie] ; Marzia Giordano [Italie] ; Annarita Panebianco [Italie] ; Francesca Passarelli [Italie] ; Andrea Trovè [Italie] ; Sofia Verkhovskaia [Italie] ; Giandomenico Russo [Italie] ; Antonio Sgadari [Italie] ; Biagio Didona [Italie] ; Damiano Abeni [Italie]Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literature.
000271 (2021) Ahmed A. Ishola [Nigeria] ; Kayode E. Adewole [Nigeria] ; Habibu Tijjani [Nigeria] ; Suliat I. Abdulai [Nigeria] ; Nnaemeka T. Asogwa [Nigeria]Phylogenic analysis of coronavirus genome and molecular studies on potential anti-COVID-19 agents from selected FDA-approved drugs.
000283 (2021) Alina Dima [Roumanie] ; Daniel Vasile Balaban [Roumanie] ; Ciprian Jurcut [Roumanie] ; Ioana Berza [Roumanie] ; Ruxandra Jurcut [Roumanie] ; Mariana Jinga [Roumanie]Perceptions of Romanian Physicians on Lockdowns for COVID-19 Prevention.
000299 (2021) Marko Boban [Croatie]Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.
000307 (2021) Shweta A. More [Inde] ; Akshay S. Patil [États-Unis] ; Nikhil S. Sakle [Inde] ; Santosh N. Mokale [Inde]Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
000358 (2021) Hassan Askari [Iran] ; Nima Sanadgol [Iran, Brésil] ; Asaad Azarnezhad [Iran] ; Amir Tajbakhsh [Iran] ; Hossein Rafiei [Canada] ; Ali Reza Safarpour [Iran] ; Seyed Mohammad Gheibihayat [Iran] ; Ehsan Raeis-Abdollahi [Iran] ; Amir Savardashtaki [Iran] ; Ali Ghanbariasad [Iran] ; Navid Omidifar [Iran]Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
000372 (2021) Jyoti Choudhary [Inde] ; Shrivardhan Dheeman [Inde] ; Vipin Sharma [Inde] ; Prashant Katiyar [Inde] ; Santosh Kumar Karn [Inde] ; Manoj Kumar Sarangi [Inde] ; Ankit Kumar Chauhan [Inde] ; Gaurav Verma [Inde] ; Nitin Baliyan [Inde]Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
000400 (2021) Yao Chen ; Mei-Xiu Li ; Guo-Dong Lu ; Han-Ming Shen [République populaire de Chine, Singapour] ; Jing Zhou [Singapour]Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.
000465 (2021) Maria Elisabetta Onori [Italie] ; Claudio Ricciardi Tenore [Italie] ; Andrea Urbani [Italie] ; Angelo Minucci [Italie]Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
000500 (2021) Avinash Kumar Jha [Royaume-Uni] ; Sudhindra Gurunath Kulkarni [Royaume-Uni]Evolution of COVID-19 management in critical care: review and perspective from a hospital in the United Kingdom.
000501 (2021) Michael Putman [États-Unis] ; Sebastian E. Sattui [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Jean W. Liew [États-Unis] ; Rebecca Grainger [Nouvelle-Zélande] ; Alí Duarte-García [États-Unis]Evidence in the Time of COVID-19.
000510 (2021) Smarajit Maiti [Inde] ; Amrita Banerjee [Inde]Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: Bioinformatics and molecular docking study.
000533 (2021) Annoor Awadasseid [Soudan] ; Yanling Wu [République populaire de Chine] ; Yoshimasa Tanaka [Japon] ; Wen Zhang [République populaire de Chine]Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines.
000569 (2021) Serap Yalç N [Turquie] ; Seda Yalç Nkaya [Turquie] ; Fahriye Ercan [Turquie]Determination of Potential Drug Candidate Molecules of the Hypericum perforatum for COVID-19 Treatment.
000571 (2021) Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde]Decoding the silent walk of COVID-19: Halting its spread using old bullets.
000589 (2021) Matthew P. Fox ; Lucy D'Agostino Mcgowan ; Bryan D. James ; Justin Lessler ; Shruti H. Mehta ; Eleanor J. MurrayConcerns About the Special Article on Hydroxychloroquine and Azithromycin in High-Risk Outpatients With COVID-19.
000645 (2021) Riadh Badraoui [Arabie saoudite, Tunisie] ; Mohd Adnan [Arabie saoudite] ; Fevzi Bardakci [Arabie saoudite, Turquie] ; Mousa M. Alreshidi [Arabie saoudite]Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "important" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "important" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    important
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021